Filtering Articles byCategory: Announcement
-
Mel-Mont Medical announces the validation of its patented self-sampling technology, Mía by XytoTest®, for molecular screening using HPV-DNA and 7-Type mRNA E6/E7.
Aug 06, 2021
KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ — Mel-Mont Medical, a boutique medical device and technology company dedicated to improving women’s …Continue Reading
Learn More -
Self-collected versus clinician-collected cervical samples for the detection of HPV infections by 14-type DNA and 7-type mRNA tests
Jun 03, 2021
C. E. Aranda Flores , G. Gomez Gutierrez, J. M. Ortiz Leon, D. Cruz Rodriguez and S. W. Sørbye Abstract …Continue Reading
Learn More -
Mel-Mont Medical, LLC announces the development of Mía by XytoTest®
May 17, 2017
Mel-Mont Medical, LLC announces the development of Mía by XytoTest® MEXICO CITY, May 17, 2017 /PRNewswire/ — Mía by XytoTest® is a preventive …Continue Reading
Learn More